IPTA 2025 - Mobis

P2.1 Biopsy Findings from the VIRTUUS Study by Center Surveillance Practices: A North American Cohort of Incident Kidney Transplant Recipients

Dr. Sandra Amaral, United States

P2.3 Comparative analysis of upper respiratory viral infections in kidney transplant recipients and the normal pediatric population

Esra Baskin, Turkey

P2.4 Management of OXA-48 and NDM-1 Carbapenemase-producing Klebsiella pneumoniae infection in a pediatric renal and liver recipient

Esra Baskin, Turkey

P2.5 Identifying risk factors for delayed graft function in children undergoing renal transplantation

Esra Baskin, Turkey

P2.6 Donor-Derived Specific Lymphocyte T-cell Therapy for Refractory Post-Transplant BK Virus Nephritis in a child, a single center experience

Dr. Massimiliano Bertacchi, Switzerland

P2.7 Left Behind – Kidney Transplant Listing Patterns in Adolescents and Young Adults

Dr. Margret Bock, United States

P2.8 Body composition monitoring in small children under 20 kg before and following renal transplantation

Prof. Rainer Büscher, Germany

P2.9 Clinical Utility of Routine MAG-3 Scan for Surveillance of Kidney Allograft Injury at 48h Post-Kidney Transplant

Serena Chan, Canada

P2.10 Challenging kidney transplant from donors with hepatitis B: Experience with pediatric recipient

Dr. Nayan Ashok Chaudhari, India

P2.11 Social drivers of health and pediatric kidney transplant outcomes: a PEDSnet study

Dr. Ashton Chen, United States

P2.12 Diabetes triggered by renal transplantation in patients with HNF1B variants - single center experience

Dr. Mirjana Cvetković, Serbia

P2.13 Kidney Transplant Immunosuppressive Approach in a Patient with SPLIS: Insights into a Lymphocyte Depleting Disease

Dr. Auda M. Plaud Gonzalez, Puerto Rico

P2.14 Characteristics of early perioperative care following pediatric kidney transplantation at Children's Hospital 2

Dr. Tuyen Minh Hoang, Viet Nam

P2.15 Hypertension in pediatric kidney transplant recipients

Siah Kim, Australia

P2.16 Transmission and persistence of Donor-Derived Anellovirus in Paediatric Kidney Transplant Recipients

Luna Klomp, Netherlands

P2.17 Pegcetacoplan for Posttransplant Patients with Complement 3 Glomerulopathy or Primary (Idiopathic) Immune-Complex Membranoproliferative Glomerulonephritis

Prof. Nicholas Webb, Switzerland

P2.18 BK virus infection in pediatric kidney allograft recipients in India

Dr. Jitendra Kumar Meena, India

P2.19 Utility of NGAL in resolution of delayed graft function after kidney transplantation: Case report

Dr. Kyle A Merrill, United States

P2.20 Longitudinal pathological study of renal graft in pediatric and adult transplants

Dr. Masaki Muramatsu, Japan

P2.21 GFR stabilizes and donor specific antibody levels fall after adding belatacept to a low dose tacrolimus/ mycophenolate/ prednisone regimen in nonadherent pediatric and adolescent kidney transplant recipients

Mrs. Lynn Maestretti, United States

P2.22 Monitoring pediatric kidney transplant rejection: assessing donor-derived cell-free DNA levels one month after rejection therapy

Dr. Auda M. Plaud Gonzalez, Puerto Rico

P2.23 Genetic Analysis in Pediatric Kidney Transplantation: Insights from a Decade of Experience at a Northern Israeli Referral Center

Dr. Moran Plonsky Toder, Israel

P2.24 2 year follow-up of a pediatric kidney transplant recipient from a donor with known autosomal dominant polycystic kidney disease

Dr. Ben C Reynolds, United Kingdom

P2.25 Endothelial p16INK4a knockout improves kidney outcome in experimental models of ischemia reperfusion injury and transplantation

Dr. Khaoula Talbi, Germany

P2.26 Treatment of acute antibody-mediated rejection after kidney transplantation targeting CD38: Two cases from two European centres

Dr. Philipp Tischer, Germany

P2.27 Isolated kidney transplantation under Lumasiran therapy in primary hyperoxaluria type 1: a case report

Dr. Diletta D Torres, Italy

P2.28 Metabolic Syndrome and Cardiovascular Outcomes in Pediatric Kidney Transplant Recipients: A Cross-Sectional Observational Study

Dr. Kinnari Vala, India

P2.29 Outcome of Low-Body-Weight Pediatric Kidney Transplant Recipients: A Retrospective Comparative Analysis from Single Centre

Dr. Kinnari Vala, India

P2.30 Outcomes of viral surveillance in pediatric kidney transplantation: a single centre retrospective study

Dr. Kinnari Vala, India

P2.31 Glomerular Filtration Rate Assessment in Pediatric Solid Organ Transplant Recipients: Accuracy of Estimation Formulas Compared to Tc-99m-DTPA

Dr. Alejandro Zarauza Santoveña, Spain

P2.32 Successful treatment of relapsing focal and segmental glomerulosclerosis using immunoadsorption and B-cell targeted therapy

Dr. Alejandro Zarauza Santoveña, Spain

P2.33 De Novo Use of tacrolimus granules in pediatric kidney transplant recipients: Integrated safety and efficacy results from two multicenter open-label studies in China

Dr. Lan Zhu, People's Republic of China

P2.34 Kidney transplantation in infants (<2 years) using size-matched infant donors: Treasure hidden in the deep sea

Dr. Lan Zhu, People's Republic of China